tailieunhanh - Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: Mortality, clinical response and radiological characteristics

Treatment for interstitial lung disease (ILD) patients with acute respiratory failure (ARF) is challenging, and literature to guide such treatment is scarce. The reported in-hospital mortality rates of ILD patients with ARF are high (62–66%). Cyclophosphamide is considered a second-line treatment in steroid-refractory ILD-associated ARF. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN